Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.49 |
| ▸ | HRH2 | P25021 | 2/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9866583 | 0.84 | ACHE (0.49) | ACHEHRH2CYP3A4CYP2D6MAPT | |
| SCHEMBL9868582 | 0.82 | ACHE (0.42) | ACHEHRH2HRH4CYP3A4CYP2D6 | |
| SCHEMBL9865132 | 0.80 | HRH2 (0.49) | HRH2HRH4HRH3CYP3A4CYP2D6 | |
| SCHEMBL9866399 | 0.78 | HRH2 (0.38) | HRH2HRH4HRH3CYP3A4CYP2D6 | |
| SCHEMBL9866381 | 0.78 | HRH2 (0.38) | HRH2HRH4HRH3CYP3A4CYP2D6 | |
| SCHEMBL10873978 | 0.76 | ACHE (0.39) | ACHEHRH2MAPTBCHE | |
| SCHEMBL11039697 | 0.76 | HRH2 (0.35) | ACHEHRH2HRH4HRH3BCHE | |
| SCHEMBL11039700 | 0.76 | HRH2 (0.35) | ACHEHRH2HRH4HRH3BCHE | |
| Impromidine SCHEMBL9771045 | 0.75 | HRH2 (0.70) | HRH2HRH4HRH3CYP3A4CYP2D6 | |
| SCHEMBL9866234 | 0.75 | PSMB5 (0.45) | HRH2HRH4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5021431-A | H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion | HEUMANN PHARMA GMBH & CO. (DE) | 1991-06-04 | — | — | US | disclosed |
| EP-0199845-A1 | Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them | HEUMANN PHARMA GMBH & CO (DE) | 1986-11-05 | — | — | EP | disclosed |